|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.925 EUR | 0.00% |
|
0.00% | +35.13% |
| 07-22 | Sopharma AD Reports Sales Results for the First Half 2026 | CI |
| 06-29 | Sopharma AD Approves Gross Dividend for 2025 | CI |
| Market Cap | 1.96B 1.18B 1.02B 950M 871M 1.64B 112B 1.67B 11.15B 4.37B 56.1B 4.42B 4.32B 185B | P/E 2024 |
12.3x | P/E 2025 | 7.16x |
|---|---|---|---|---|---|
| Enterprise Value | 2.5B 1.5B 1.3B 1.21B 1.11B 2.09B 143B 2.13B 14.23B 5.58B 71.61B 5.64B 5.51B 237B | EV / Sales 2024 |
0.66x | EV / Sales 2025 | 0.76x |
| Free-Float |
31.06% | Yield 2024 |
2.68% | Yield 2025 | - |
| 1 month | +1.32% | ||
| 3 months | +3.22% | ||
| 6 months | -0.77% | ||
| Current year | +35.13% |
| 1 week | 1.9 |  | 1.93 |
| 1 month | 1.84 | | 1.93 |
| Current year | 1.41 | | 2 |
| 1 year | 1.23 | | 2 |
| 3 years | 0.93 | | 2 |
| 5 years | 0.58 | | 2 |
| 10 years | 0.41 | | 2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CEO | Chief Executive Officer | 42 | 01/10/2000 |
Boris Borisov
DFI | Director of Finance/CFO | - | 01/01/2002 |
Ivaylo Mechev
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Ognian Donev
CHM | Chairman | 42 | 19/05/2010 |
| Director/Board Member | 63 | 19/05/2010 | |
| Director/Board Member | 61 | 12/07/2011 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 9/30/20 A | Donev Investments Ad
| Buy | Company | 25,489 | 0.0189% | |
| 9/30/20 A | Buy | Chief Executive Officer | 12,000 | 0.0089% | ||
| 9/29/20 A | Donev Investments Ad
| Buy | Company | 9,000 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +51.84% | +105.39% | 1.18B | |
| +2.93% | +0.70% | -23.66% | -23.95% | 15.83B | |
| +2.23% | +1.24% | -26.06% | -34.88% | 7.38B | |
| +2.69% | +2.44% | -22.65% | -11.95% | 6.21B | |
| -1.42% | -2.55% | -7.44% | -33.18% | 3.98B | |
| +0.89% | +0.31% | -22.02% | -37.47% | 3.3B | |
| -1.19% | -2.06% | -41.84% | -24.45% | 3.12B | |
| -2.23% | -7.11% | -0.45% | -39.83% | 2.95B | |
| +11.05% | +10.88% | +119.48% | - | 2.78B | |
| 0.00% | -3.88% | -14.65% | +5.61% | 2.62B | |
| Average | +1.49% | -0.37% | +1.25% | -10.52% | 4.94B | |
| Weighted average by Cap. | +1.97% | -0.76% | -11.90% | -21.94% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.14B 1.28B 1.11B 1.04B 952M 1.79B 122B 1.82B 12.18B 4.78B 61.3B 4.83B 4.72B 203B | 2.63B 1.58B 1.37B 1.28B 1.17B 2.2B 150B 2.24B 14.99B 5.88B 75.43B 5.94B 5.81B 249B |
| Net income | 77.85M 46.75M 40.44M 37.77M 34.65M 65.16M 4.45B 66.2M 443M 174M 2.23B 176M 172M 7.37B | 134M 80.19M 69.37M 64.78M 59.42M 112M 7.63B 114M 760M 298M 3.83B 301M 295M 12.65B |
| Net Debt | 444M 267M 231M 215M 198M 372M 25.39B 378M 2.53B 992M 12.73B 1B 980M 42.07B | 541M 325M 281M 263M 241M 453M 30.94B 460M 3.08B 1.21B 15.51B 1.22B 1.19B 51.27B |
Employees
6,005
Sector
Drug Retailers
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/08/26 | €1.925 | 0.00% | 1,654 |
| 06/08/26 | €1.925 | +0.26% | 4,177 |
| 05/08/26 | €1.920 | +0.26% | 1,486 |
| 04/08/26 | €1.915 | -0.52% | 7,735 |
| 03/08/26 | €1.925 | 0.00% | 2,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SFA Stock
Select your edition
All financial news and data tailored to specific country editions
